Vanda, Probiomed in deal for schizophrenia drug Fanapt for Mexico
14 July 2011
Nancy Faigen
Please Login to read the full article.
14 July 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Vanda, Biotoscana in deal for schizophrenia drug Fanapt in Argentina
- Vanda acquires Lilly's NK-1 receptor antagonist and could target alcohol dependence
- Addex seeks partner for dyskinesia drug after positive Phase II
- Lurasidone on track for US bipolar filing following positive top-line PhIII results
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
